California Public Employees Retirement System cut its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 0.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 478,030 shares of the company's stock after selling 3,232 shares during the quarter. California Public Employees Retirement System owned 0.47% of Encompass Health worth $44,146,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. BNP Paribas Financial Markets boosted its position in Encompass Health by 38.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 38,397 shares of the company's stock worth $3,711,000 after acquiring an additional 10,591 shares during the period. Townsquare Capital LLC purchased a new stake in shares of Encompass Health in the third quarter worth approximately $405,000. Point72 Asia Singapore Pte. Ltd. grew its position in Encompass Health by 62.0% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 1,095 shares of the company's stock valued at $106,000 after purchasing an additional 419 shares in the last quarter. Benjamin Edwards Inc. increased its stake in Encompass Health by 37.2% in the 3rd quarter. Benjamin Edwards Inc. now owns 6,298 shares of the company's stock valued at $609,000 after buying an additional 1,707 shares during the period. Finally, IHT Wealth Management LLC purchased a new stake in Encompass Health in the 3rd quarter worth approximately $233,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Encompass Health
In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.10% of the company's stock.
Analyst Ratings Changes
Several equities analysts have recently commented on EHC shares. Royal Bank of Canada restated an "outperform" rating and set a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. Barclays upped their target price on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. StockNews.com lowered Encompass Health from a "buy" rating to a "hold" rating in a report on Thursday. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Finally, KeyCorp lifted their target price on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, Encompass Health presently has a consensus rating of "Buy" and a consensus target price of $107.67.
Check Out Our Latest Stock Report on EHC
Encompass Health Stock Performance
Shares of NYSE:EHC traded down $1.21 during trading on Monday, reaching $96.75. The stock had a trading volume of 1,302,566 shares, compared to its average volume of 649,262. The stock has a fifty day simple moving average of $99.26 and a two-hundred day simple moving average of $97.78. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 52 week low of $78.53 and a 52 week high of $104.55. The firm has a market capitalization of $9.74 billion, a price-to-earnings ratio of 21.69, a P/E/G ratio of 2.31 and a beta of 0.87.
Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.
Encompass Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.70%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio is currently 15.25%.
About Encompass Health
(
Free Report)
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Read More

Before you consider Encompass Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.
While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.